This is the authors' abstract. We don't add key points for this paper.
Introduction: Cancer cachexia is characterized by a progressive loss of body weight and muscle mass, mainly caused by inflammation and anorexia/malnutrition that lead to energy wasting and muscle protein catabolism. These alterations represent the targets of several drugs and multimodal therapeutic approaches that are currently under clinical evaluation.Areas covered: In this review, the molecular mechanisms underlying muscle wasting in cancer and the available treatments are discussed. Afterwards, a particular attention is given to recently discovered new potential targets, focusing mainly on microRNAs, that are emerging as new drivers in the complex scenario of muscle mass control.Expert commentary: Moreover, microRNAs are dysregulated also in cancer, representing an attractive class of molecules for both fighting the tumor and managing cachexia.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Beltrà et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: